Dean L. Schorno, EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS INC (RIGL), sold 5,389 shares at $1.66 ($9K) on 2023-02-02, disclosed to the SEC on 2023-02-06.
Open-market sale of $9k RIGL by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RIGL | BUY | 2019-05-23 | $206K | — | Filing → |
| GHDX | SELL | 2014-06-13 | $110K | — | Filing → |
| GHDX | SELL | 2014-05-13 | $100K | — | Filing → |